Literature DB >> 19996940

Increased prevalence of subclinical coronary atherosclerosis detected by coronary computed tomography angiography in HIV-infected men.

Janet Lo1, Suhny Abbara, Leon Shturman, Anand Soni, Jeffrey Wei, Jose A Rocha-Filho, Khurram Nasir, Steven K Grinspoon.   

Abstract

OBJECTIVE: The degree of subclinical coronary atherosclerosis in HIV-infected patients is unknown. We investigated the degree of subclinical atherosclerosis and the relationship of traditional and nontraditional risk factors to early atherosclerotic disease using coronary computed tomography angiography. DESIGN AND METHODS: Seventy-eight HIV-infected men (age 46.5 +/- 6.5 years and duration of HIV 13.5 +/- 6.1 years, CD4 T lymphocytes 523 +/- 282; 81% undetectable viral load), and 32 HIV-negative men (age 45.4 +/- 7.2 years) with similar demographic and coronary artery disease (CAD) risk factors, without history or symptoms of CAD, were prospectively recruited. 64-slice multidetector row computed tomography coronary angiography was performed to determine prevalence of coronary atherosclerosis, coronary stenosis, and quantitative plaque burden. RESULTS HIV-infected men demonstrated higher prevalence of coronary atherosclerosis than non-HIV-infected men (59 vs. 34%; P = 0.02), higher coronary plaque volume [55.9 (0-207.7); median (IQR) vs. 0 (0-80.5) microl; P = 0.02], greater number of coronary segments with plaque [1 (0-3) vs. 0 (0-1) segments; P = 0.03], and higher prevalence of Agatston calcium score more than 0 (46 vs. 25%, P = 0.04), despite similar Framingham 10-year risk for myocardial infarction, family history of CAD, and smoking status. Among HIV-infected patients, Framingham score, total cholesterol, low-density lipoprotein, CD4/CD8 ratio, and monocyte chemoattractant protein 1 were significantly associated with plaque burden. Duration of HIV infection was significantly associated with plaque volume (P = 0.002) and segments with plaque (P = 0.0009) and these relationships remained significant after adjustment for age, traditional risk factors, or duration of antiretroviral therapy. A total of 6.5% (95% confidence interval 2-15%) of our study population demonstrated angiographic evidence of obstructive CAD (>70% luminal narrowing) as compared with 0% in controls.
CONCLUSION: Young, asymptomatic, HIV-infected men with long-standing HIV disease demonstrate an increased prevalence and degree of coronary atherosclerosis compared with non-HIV-infected patients. Both traditional and nontraditional risk factors contribute to atherosclerotic disease in HIV-infected patients.

Entities:  

Mesh:

Year:  2010        PMID: 19996940      PMCID: PMC3154841          DOI: 10.1097/QAD.0b013e328333ea9e

Source DB:  PubMed          Journal:  AIDS        ISSN: 0269-9370            Impact factor:   4.177


  41 in total

1.  Cardiovascular risks of antiretroviral therapy.

Authors:  James H Stein
Journal:  N Engl J Med       Date:  2007-04-26       Impact factor: 91.245

Review 2.  Insights into the role of infection in atherogenesis and in plaque rupture.

Authors:  Stephen E Epstein; Jianhui Zhu; Amir H Najafi; Mary S Burnett
Journal:  Circulation       Date:  2009-06-23       Impact factor: 29.690

3.  Linking immune-mediated arterial inflammation and cholesterol-induced atherosclerosis in a transgenic mouse model.

Authors:  B Ludewig; S Freigang; M Jäggi; M O Kurrer; Y C Pei; L Vlk; B Odermatt; R M Zinkernagel; H Hengartner
Journal:  Proc Natl Acad Sci U S A       Date:  2000-11-07       Impact factor: 11.205

4.  Subclinical coronary atherosclerosis, HIV infection and antiretroviral therapy: Multicenter AIDS Cohort Study.

Authors:  Lawrence A Kingsley; Juliana Cuervo-Rojas; Alvaro Muñoz; Frank J Palella; Wendy Post; Mallory D Witt; Matthew Budoff; Lewis Kuller
Journal:  AIDS       Date:  2008-08-20       Impact factor: 4.177

5.  Increased acute myocardial infarction rates and cardiovascular risk factors among patients with human immunodeficiency virus disease.

Authors:  Virginia A Triant; Hang Lee; Colleen Hadigan; Steven K Grinspoon
Journal:  J Clin Endocrinol Metab       Date:  2007-04-24       Impact factor: 5.958

6.  Association of C-reactive protein and HIV infection with acute myocardial infarction.

Authors:  Virginia A Triant; James B Meigs; Steven K Grinspoon
Journal:  J Acquir Immune Defic Syndr       Date:  2009-07-01       Impact factor: 3.731

7.  Preclinical atherosclerosis due to HIV infection: carotid intima-medial thickness measurements from the FRAM study.

Authors:  Carl Grunfeld; Joseph A C Delaney; Christine Wanke; Judith S Currier; Rebecca Scherzer; Mary L Biggs; Phyllis C Tien; Michael G Shlipak; Stephen Sidney; Joseph F Polak; Daniel O'Leary; Peter Bacchetti; Richard A Kronmal
Journal:  AIDS       Date:  2009-09-10       Impact factor: 4.177

8.  Role of viral replication, antiretroviral therapy, and immunodeficiency in HIV-associated atherosclerosis.

Authors:  Priscilla Y Hsue; Peter W Hunt; Amanda Schnell; S Craig Kalapus; Rebecca Hoh; Peter Ganz; Jeffrey N Martin; Steven G Deeks
Journal:  AIDS       Date:  2009-06-01       Impact factor: 4.177

9.  Accelerated coronary atherosclerosis and arteriosclerosis in young human-immunodeficiency-virus-positive patients.

Authors:  A Tabib; C Leroux; J F Mornex; R Loire
Journal:  Coron Artery Dis       Date:  2000-02       Impact factor: 1.439

10.  Accuracy of dual-source CT in the characterisation of non-calcified plaque: use of a colour-coded analysis compared with virtual histology intravascular ultrasound.

Authors:  H Brodoefel; C Burgstahler; M Heuschmid; A Reimann; F Khosa; A Kopp; S Schroeder; C D Claussen; M E Clouse
Journal:  Br J Radiol       Date:  2009-03-30       Impact factor: 3.039

View more
  170 in total

1.  Editorial Commentary: Clinical management of cardiovascular disease in HIV-infected patients.

Authors:  Alison Kearns; Tricia H Burdo; Xuebin Qin
Journal:  Trends Cardiovasc Med       Date:  2017-07-22       Impact factor: 6.677

2.  Elevated levels of monocyte activation markers are associated with subclinical atherosclerosis in men with and those without HIV infection.

Authors:  Rebeccah A McKibben; Joseph B Margolick; Steven Grinspoon; Xiuhong Li; Frank J Palella; Lawrence A Kingsley; Mallory D Witt; Richard T George; Lisa P Jacobson; Matthew Budoff; Russell P Tracy; Todd T Brown; Wendy S Post
Journal:  J Infect Dis       Date:  2014-10-30       Impact factor: 5.226

3.  Cardiovascular disease in HIV: traditional and nontraditional risk factors.

Authors:  Steven K Grinspoon
Journal:  Top Antivir Med       Date:  2014 Sep-Oct

4.  Noninvasive coronary imaging for atherosclerosis in human immunodeficiency virus infection.

Authors:  Ahmed M Gharib; Khaled Z Abd-Elmoniem; Roderic I Pettigrew; Colleen Hadigan
Journal:  Curr Probl Diagn Radiol       Date:  2011 Nov-Dec

5.  Increased coronary artery calcium score and noncalcified plaque among HIV-infected men: relationship to metabolic syndrome and cardiac risk parameters.

Authors:  Kathleen V Fitch; Janet Lo; Suhny Abbara; Brian Ghoshhajra; Leon Shturman; Anand Soni; Rachel Sacks; Jeffrey Wei; Steven Grinspoon
Journal:  J Acquir Immune Defic Syndr       Date:  2010-12       Impact factor: 3.731

6.  Associations between HIV infection and subclinical coronary atherosclerosis.

Authors:  Wendy S Post; Matthew Budoff; Lawrence Kingsley; Frank J Palella; Mallory D Witt; Xiuhong Li; Richard T George; Todd T Brown; Lisa P Jacobson
Journal:  Ann Intern Med       Date:  2014-04-01       Impact factor: 25.391

7.  Increased coronary atherosclerosis and immune activation in HIV-1 elite controllers.

Authors:  Florencia Pereyra; Janet Lo; Virginia A Triant; Jeffrey Wei; Maria J Buzon; Kathleen V Fitch; Janice Hwang; Jennifer H Campbell; Tricia H Burdo; Kenneth C Williams; Suhny Abbara; Steven K Grinspoon
Journal:  AIDS       Date:  2012-11-28       Impact factor: 4.177

8.  Low thigh muscle mass is associated with coronary artery stenosis among HIV-infected and HIV-uninfected men: The Multicenter AIDS Cohort Study (MACS).

Authors:  Martin Tibuakuu; Di Zhao; Ankita Saxena; Todd T Brown; Lisa P Jacobson; Frank J Palella; Mallory D Witt; Susan L Koletar; Joseph B Margolick; Eliseo Guallar; Sai Krishna C Korada; Matthew J Budoff; Wendy S Post; Erin D Michos
Journal:  J Cardiovasc Comput Tomogr       Date:  2018-01-31

9.  Increased coronary atherosclerotic plaque vulnerability by coronary computed tomography angiography in HIV-infected men.

Authors:  Markella V Zanni; Suhny Abbara; Janet Lo; Bryan Wai; David Hark; Eleni Marmarelis; Steven K Grinspoon
Journal:  AIDS       Date:  2013-05-15       Impact factor: 4.177

10.  Noncalcified coronary atherosclerotic plaque and immune activation in HIV-infected women.

Authors:  Kathleen V Fitch; Suman Srinivasa; Suhny Abbara; Tricia H Burdo; Kenneth C Williams; Peace Eneh; Janet Lo; Steven K Grinspoon
Journal:  J Infect Dis       Date:  2013-09-16       Impact factor: 5.226

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.